Escape from sodium-retaining effects of deoxycorticosterone in hypotensive and hypertensive dogs.
D000618:Aminohippuric Acids / Q000032:analysis; D000818:Animals; D001794:Blood Pressure; D003404:Creatinine / Q000032:analysis; D003900:Desoxycorticosterone / Q000494:pharmacology; D004285:Dogs; D004809:Ephedrine / Q000494:pharmacology; D005260:Female; D006145:Guanethidine / Q000494:pharmacology; D006830:Hydralazine / Q000494:pharmacology; D006973:Hypertension / Q000139:chemically induced / Q000378:metabolism*; D007022:Hypotension / Q000139:chemically induced / Q000378:metabolism*; D007668:Kidney / Q000187:drug effects; D008297:Male; D011188:Potassium / Q000652:urine; D012964:Sodium / Q000378:metabolism* / Q000652:urine
D000618:Aminohippuric Acids; D006830:Hydralazine; D003900:Desoxycorticosterone; D012964:Sodium; D003404:Creatinine; D004809:Ephedrine; D011188:Potassium; D006145:Guanethidine